Test Menu Category: Next Generation Sequencing

MPLN's Next Generation Sequencing (NGS) Gene Panels target hotspot mutations and can be ordered individually, or in the case of oncology are orderable in conjunction with other appropriate molecular and cellular tests targeting tumor site. The resulting analyses and interpretation enables selection of appropriate therapies based on guidelines and selection of applicable clinical trials.


Next Generation Sequencing Tests

BRAF Mutation Analysis by Next Generation Sequencing

CALR Type 1 / Type 2 Mutation Analysis by Next Generation Sequencing

Colorectal Cancer Panel by Next Generation Sequencing

Cystic Fibrosis MiSeqDx 139-Variant Assay by Next Generation Sequencing

Cystic Fibrosis MiSeqDx Clinical Sequencing Assay by Next Generation Sequencing

EGFR Mutation Analysis by Next Generation Sequencing

GIST Panel - KIT, PDGFRA, BRAF by Next Generation Sequencing

IDH1/IDH2 Mutation Analysis by Next Generation Sequencing

IgVH Somatic Hypermutation by Next Generation Sequencing

JAK2 Exon12 Mutation Analysis by Next Generation Sequencing

KRAS Mutation Analysis by Next Generation Sequencing

Lung Cancer Panel by Next Generation Sequencing

Melanoma Cancer Panel by Next Generation Sequencing

MPL Exon 10 Mutation Analysis by Next Generation Sequencing

MYD88 p.L265P Mutation Analysis by Next Generation Sequencing

Myeloid Extended Mutation Analysis Panel by Next Generation Sequencing

Myeloproliferative Neoplasms Core Mutation Analysis Panel by Next Generation Sequencing

Solid Tumor 8 Gene Panel by Next Generation Sequencing